Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention
Cholesteryl ester transfer protein (CETP) plays a key role in lipoprotein metabolism, and its activity has been linked to the risk of atherosclerosis (AS). CETP inhibitors, such as obicetrapib, represent a novel approach in immunotherapy to reduce the risk of atherosclerotic cardiovascular disease (...
Saved in:
Main Authors: | Wenhui Hu, Han Feng, Ying Liu, Xiaoshuang Xu, Ping Zhou, Zhonghua Sun, Xinyu Tao, Jiahui Yang, Jun Wu, Chen Qu, Zhengxia Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2462466 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
by: Wu Helena T., et al.
Published: (2025-01-01) -
Sphingolipid metabolites involved in the pathogenesis of atherosclerosis: perspectives on sphingolipids in atherosclerosis
by: Fufangyu Zhao, et al.
Published: (2025-02-01) -
Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications
by: Nimeet Desai, et al.
Published: (2025-02-01) -
Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives
by: Yunxiang Hu, et al.
Published: (2025-02-01) -
Mitochondrial DNA in atherosclerosis research progress: a mini review
by: Zheng Liu, et al.
Published: (2025-02-01)